54 Pathways

• Disease,
• FGFR1c ligand binding and activation,
• B Cell Activation,
• PLC-gamma1 signalling,
• Signaling by ERBB2,
• Phospholipid metabolism,
• Signaling by NGF,
• Signaling Pathways,
• Phospholipase C-mediated cascade,
• FGFR1 ligand binding and activation,
• Synthesis of IP3 and IP4 in the cytosol,
• PIP3 activates AKT signaling,
• DAG and IP3 signaling,
• Inositol phosphate metabolism,
• Fc epsilon receptor (FCERI) signaling,
• Metabolism,
• Signaling by ERBB4,
• Adaptive Immune System,
• Downstream Signaling Events Of B Cell Receptor (BCR),
• Downstream signaling of activated FGFR,
• GAB1 signalosome,
• Metabolism of lipids and lipoproteins,
• FGFR2c ligand binding and activation,
• Negative regulation of the PI3K/AKT network,
• Signaling by FGFR,
• PI3K/AKT Signaling in Cancer,
• PI3K/AKT activation,
• Role of phospholipids in phagocytosis,
• Fcgamma receptor (FCGR) dependent phagocytosis,
• PI Metabolism,
• Immune System,
• Role of LAT2/NTAL/LAB on calcium mobilization,
• Synthesis of PIPs at the plasma membrane,
• FGFR4 ligand binding and activation,
• FGFR3 ligand binding and activation,
• PI3K events in ERBB2 signaling,
• FGFR2 ligand binding and activation,
• FGFR3c ligand binding and activation,
• Downstream signal transduction,
• DAP12 interactions,
• PI3K events in ERBB4 signaling,
• Signaling by EGFR,
• PLCG1 events in ERBB2 signaling,
• Signaling by PDGF,
• Signaling by SCF-KIT,
• Signaling by EGFR in Cancer,
• EGFR interacts with phospholipase C-gamma,
• NGF signalling via TRKA from the plasma membrane,
• PI-3K cascade,
• FGFR ligand binding and activation,
• Signaling by FGFR in disease,
• DAP12 signaling,
• FGFR3b ligand binding and activation,
• Innate Immune System